Drugs / 99mTc-ZHER2:41071
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05203497 | Dec 2021 → Mar 2023 | female breast carcinoma | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-ZHER2:41071 | “One single injection of 99mTc-ZHER2:41071, followed by gamma camera imaging after 2, 4, 6 and 24 hours.” NCT05203497 ↗ |
| Route | Intravenous | “after single intravenous injection” NCT05203497 ↗ |